Next Article in Journal
Genotype–Phenotype Associations in Phelan–McDermid Syndrome: Insights into Novel Genes Beyond SHANK3
Next Article in Special Issue
The Quantum Paradox in Pharmaceutical Science: Understanding Without Comprehending—A Centennial Reflection
Previous Article in Journal
Exploring the Anti-Leukemic Effect of the Synthetic Retinoid ST1926 on Malignant T Cells: A Comprehensive Proteomics Approach
Previous Article in Special Issue
Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 26
Issue 10
10.3390/ijms26104654
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Int. J. Mol. Sci. 2025, 26(2), 736.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Al Subait et al. Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds. Int. J. Mol. Sci. 2025, 26, 736

by
Arwa Al Subait
1,2,
Raghad H. Alghamdi
3,
Rizwan Ali
1,
Amani Alsharidah
4,
Sarah Huwaizi
1,
Reem A. Alkhodier
5,6,
Aljawharah Saud Almogren
1,
Barrak A. Alzomia
1,
Ahmed Alaskar
1 and
Mohamed Boudjelal
1,*
1
Medical Research Core Facility and Platforms (MRCFP)-Drug Discovery Platform, King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs (MNGHA), Riyadh 11481, Saudi Arabia
2
Clinical Laboratory Sciences Department, College of Applied Medical Sciences, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs (MNGHA), Riyadh 11481, Saudi Arabia
3
King Abdulaziz and His Companions Foundation for Giftedness and Creativity (MAWHIBA), Riyadh 11481, Saudi Arabia
4
College of Science, King Saud University, Riyadh 11459, Saudi Arabia
5
Department of Pharmaceutical Sciences, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs (MNGHA), Riyadh 11481, Saudi Arabia
6
King Abdullah International Medical Research Center (KAIMRC), Ministry of National Guard Health Affairs (MNGHA), Riyadh 11481, Saudi Arabia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2025, 26(10), 4654; https://doi.org/10.3390/ijms26104654
Submission received: 21 March 2025 / Accepted: 27 March 2025 / Published: 13 May 2025
(This article belongs to the Special Issue Recombinant Proteins, Protein Folding and Drug Discovery)
Versions Notes
In the published publication [1], there was an error regarding the affiliation for Reem A. Alkhodier. In addition to affiliation 5, the updated affiliation should include: King Abdullah International Medical Research Center (KAIMRC), Ministry of National Guard Health Affairs (MNGHA), Riyadh 11481, Saudi Arabia.
Ahmed Alaskar was misspelled in the original publication. The corrected spelling appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Al Subait, A.; Alghamdi, R.H.; Ali, R.; Alsharidah, A.; Huwaizi, S.; Alkhodier, R.A.; Almogren, A.S.; Alzomia, B.A.; Alaskar, A.; Boudjelal, M. Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds. Int. J. Mol. Sci. 2025, 26, 736. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Subait, A.A.; Alghamdi, R.H.; Ali, R.; Alsharidah, A.; Huwaizi, S.; Alkhodier, R.A.; Almogren, A.S.; Alzomia, B.A.; Alaskar, A.; Boudjelal, M. Correction: Al Subait et al. Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds. Int. J. Mol. Sci. 2025, 26, 736. Int. J. Mol. Sci. 2025, 26, 4654. https://doi.org/10.3390/ijms26104654

AMA Style

Subait AA, Alghamdi RH, Ali R, Alsharidah A, Huwaizi S, Alkhodier RA, Almogren AS, Alzomia BA, Alaskar A, Boudjelal M. Correction: Al Subait et al. Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds. Int. J. Mol. Sci. 2025, 26, 736. International Journal of Molecular Sciences. 2025; 26(10):4654. https://doi.org/10.3390/ijms26104654

Chicago/Turabian Style

Subait, Arwa Al, Raghad H. Alghamdi, Rizwan Ali, Amani Alsharidah, Sarah Huwaizi, Reem A. Alkhodier, Aljawharah Saud Almogren, Barrak A. Alzomia, Ahmed Alaskar, and Mohamed Boudjelal. 2025. "Correction: Al Subait et al. Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds. Int. J. Mol. Sci. 2025, 26, 736" International Journal of Molecular Sciences 26, no. 10: 4654. https://doi.org/10.3390/ijms26104654

APA Style

Subait, A. A., Alghamdi, R. H., Ali, R., Alsharidah, A., Huwaizi, S., Alkhodier, R. A., Almogren, A. S., Alzomia, B. A., Alaskar, A., & Boudjelal, M. (2025). Correction: Al Subait et al. Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds. Int. J. Mol. Sci. 2025, 26, 736. International Journal of Molecular Sciences, 26(10), 4654. https://doi.org/10.3390/ijms26104654

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop